Hypoxia-Inducible Factor-1α in Vascular Smooth Muscle Regulates Blood Pressure Homeostasis Through a Peroxisome Proliferator-Activated Receptor-γ-Angiotensin II Receptor Type 1 Axis

被引:27
|
作者
Huang, Yan [1 ,2 ]
Di Lorenzo, Annarita [4 ]
Jiang, Weidong [1 ,2 ]
Cantalupo, Anna [4 ,5 ]
Sessa, William C. [2 ,3 ]
Giordano, Frank J. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[4] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA
[5] Univ Naples Federico II, Dept Pharmacol, Naples, Italy
基金
美国国家卫生研究院;
关键词
angiotensins; HIF-1; hypertension; muscle; smooth; vascular; PPAR-; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; HYPERTENSION; OXYGEN; HIF-1-ALPHA; RESISTANCE; HEART; ANGIOGENESIS; HYPERTROPHY; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.111.00160
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a major worldwide health issue for which only a small proportion of cases have a known mechanistic pathogenesis. Of the defined causes, none have been directly linked to heightened vasoconstrictor responsiveness, despite the fact that vasomotor tone in resistance vessels is a fundamental determinant of blood pressure. Here, we reported a previously undescribed role for smooth muscle hypoxia-inducible factor-1 (HIF-1) in controlling blood pressure homeostasis. The lack of HIF-1 in smooth muscle caused hypertension in vivo and hyperresponsiveness of resistance vessels to angiotensin II stimulation ex vivo. These data correlated with an increased expression of angiotensin II receptor type I in the vasculature. Specifically, we show that HIF-1, through peroxisome proliferator-activated receptor-, reciprocally defined angiotensin II receptor type I levels in the vessel wall. Indeed, pharmacological blockade of angiotensin II receptor type I by telmisartan abolished the hypertensive phenotype in smooth muscle cell-HIF-1-KO mice. These data revealed a determinant role of a smooth muscle HIF-1/peroxisome proliferator-activated receptor-/angiotensin II receptor type I axis in controlling vasomotor responsiveness and highlighted an important pathway, the alterations of which may be critical in a variety of hypertensive-based clinical settings.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [41] Vascular Smooth Muscle Cell Peroxisome Proliferator-Activated Receptor-γ Mediates Pioglitazone-Reduced Vascular Lesion Formation
    Hamblin, Milton
    Chang, Lin
    Zhang, Hengmin
    Yang, Kun
    Zhang, Jifeng
    Chen, Y. Eugene
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (02) : 352 - 359
  • [42] Loss of Function of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) In Vascular Smooth Muscle Augments Angiotensin II (ANG) Signaling
    Carrillo-Sepulveda, Maria A.
    Ketsawatsomkron, Pimonrat
    Grobe, Justin L.
    Sigmund, Curt D.
    HYPERTENSION, 2011, 58 (05) : E62 - E62
  • [43] Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor α expression during hypoxia (vol 166, pg 7543, 2001)
    Narravula, S
    Colgan, SP
    JOURNAL OF IMMUNOLOGY, 2002, 168 (06): : 3113 - 3113
  • [44] Bcr Kinase Activation by Angiotensin II Inhibits Peroxisome Proliferator-Activated Receptor γ Transcriptional Activity in Vascular Smooth Muscle Cells
    Alexis, Jeffrey D.
    Wang, Nadan
    Che, Wenyi
    Lerner-Marmarosh, Nicole
    Sahni, Abha
    Korshunov, Vyacheslav A.
    Zou, Yiping
    Ding, Bo
    Yan, Chen
    Berk, Bradford C.
    Abe, Jun-ichi
    CIRCULATION RESEARCH, 2009, 104 (01) : 69 - 78
  • [45] Telmisartan downregulates angiotensin II type-1 receptor through peroxisome proliferator activated receptor gamma
    Imayama, Ikuyo
    Inanaga, Keita
    Ohtsubo, Hideki
    Sunagawa, Kenji
    Ichiki, Toshihiro
    CIRCULATION, 2006, 114 (18) : 46 - 46
  • [46] Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension
    Zhang, Lili
    Xie, Peng
    Wang, Jingzhou
    Yang, Qingwu
    Fang, Chuanqin
    Zhou, Shuang
    Li, Jingcheng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (18) : 13666 - 13677
  • [47] HYPOXIA-INDUCIBLE FACTOR-1α REGULATES EXPRESSION OF mRNA FOR MACROPHAGE SCAVENGER RECEPTOR 1
    Shirato, Ken
    Kizaki, Takako
    Sakurai, Takuya
    Ogasawara, Junetsu
    Ishibashi, Yoshinaga
    Saitoh, Daizoh
    Haga, Shukoh
    Imaizumi, Kazuhiko
    Ohno, Hideki
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 437 - 437
  • [48] Hypoxia-Inducible Factor-1α Deficiency in Smooth Muscle Cells Suppresses Angiotensin II-Induced Vascular Remodeling in Mice
    Imanishi, Masaki
    Ishizawa, Keisuke
    Kihira, Yoshitaka
    Ikeda, Yasumasa
    Yamano, Noriko
    Ishizawa, Yuki
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    Tomita, Shuhei
    HYPERTENSION, 2011, 58 (05) : E145 - E145
  • [49] Angiotensin type 1 receptor blockers exhibit peroxisome proliferator-activated receptor alpha agonistic activity
    Yin, Shi-nan
    Jing, Dan-qing
    Mu, Yi-ming
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S17 - S17
  • [50] Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ
    Casimiro-Garcia, Agustin
    Filzen, Gary F.
    Flynn, Declan
    Bigge, Christopher F.
    Chen, Jing
    Davis, Jo Ann
    Dudley, Danette A.
    Edmunds, Jeremy J.
    Esmaeil, Nadia
    Geyer, Andrew
    Heemstra, Ronald J.
    Jalaie, Mehran
    Ohren, Jeffrey F.
    Ostroski, Robert
    Ellis, Teresa
    Schaum, Robert P.
    Stoner, Chad
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (12) : 4219 - 4233